Cogent Biosciences Inc (COGT)

Investing Cash Flow

$14.28M

Quarterly · Period ending: · USD

COGT logo

COGT Investing Cash Flow

Latest reported$14.28M
COGT Quarterly Cash from Investing ($0.00 → $14.28M)
High-resolution chart · PNG

COGT investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Cogent Biosciences Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
14,280,000
-36,457,000
-322,769,000
-155,046,000
8,910,000
69,379,000
61,671,000
60,186,000
-84,625,000
1,044,000
10,489,000
-90,536,000
-77,661,000
59,884,000
28,411,000
-151,544,000
-1,144,000
-441,000
-433,000
-1,163,000
-123,000
0
0
8,420,000
0
0
-13,000
226,000
7,996,000
14,950,000
15,000,000
9,914,000
-41,370,000
5,925,000
4,825,000
5,725,000
3,783,000
-820,000
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.